Skip to main content

A22-301

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

PharmaEssentia USA Corporation

Start Date

July 17, 2023

End Date

July 14, 2028
 

Administered By

Duke Cancer Institute

Awarded By

PharmaEssentia USA Corporation

Start Date

July 17, 2023

End Date

July 14, 2028